Home > Financial Ratios > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
EV/Net Sales

    Back to All Ratios
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

LINCOLN PHARMACEUTICALS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 1.742.001.271.281.03

What is the latest EV/Net Sales ratio of LINCOLN PHARMACEUTICALS ?

The latest EV/Net Sales ratio of LINCOLN PHARMACEUTICALS is 1.74 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20251.74
Mar20242.00
Mar20231.27
Mar20221.28
Mar20211.03

How is EV/Net Sales of LINCOLN PHARMACEUTICALS Trending?

Years EV/Net Sales % Change
Mar2025 1.74
-13.00
Mar2024 2
57.48
Mar2023 1.27
-0.78
Mar2022 1.28
24.27
Mar2021 1.03 -

Other Financial Ratios of LINCOLN PHARMACEUTICALS


Compare EV/Net Sales ratio of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,275.6 Cr 3.2% 39.4% 12.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

3.2%

39.4%

12.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses